Emad B Basalious
Overview
Explore the profile of Emad B Basalious including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farag M, El-Sebaie W, Basalious E, El-Gazayerly O
AAPS PharmSciTech
. 2024 Oct;
25(8):250.
PMID: 39433620
This study aimed to prepare a combined self-nanoemulsifying and self-assembled cubic nanoparticles (SNE/SAC) lyophilized tablet eliciting biphasic release pattern escorted with enhanced bioavailability for drugs hampered with slow dissolution and...
2.
Hamdy N, Basalious E, El-Sisi M, Nasr M, Kabel A, Nossier E, et al.
Curr Med Res Opin
. 2024 Oct;
40(11):1943-1961.
PMID: 39412377
The development of therapies followed a generalized approach for a long time, assuming that a single treatment could effectively address various patient populations. However, recent breakthroughs have revealed the limitations...
3.
Ibrahim M, Basalious E, El-Nabarawi M, Makhlouf A, Sayyed M, Ibrahim I
Drug Deliv Transl Res
. 2024 Feb;
14(9):2539-2557.
PMID: 38376620
Mirtazapine (MZPc) is an antidepressant drug which is approved by the FDA. It has low bioavailability, which is only 50%, in spite of its rapid absorption when orally administered owing...
4.
Sokolov D, Sharda N, Banerjee A, Denisenko K, Basalious E, Shukla H, et al.
Curr Pharm Des
. 2023 Dec;
30(1):31-47.
PMID: 38151840
Background: Medulloblastomas (MDB) are malignant, aggressive brain tumors that primarily affect children. The survival rate for children under 14 is approximately 72%, while for ages 15 to 39, it is...
5.
Embarez D, Razek A, Basalious E, Mahmoud M, Hamdy N
J Genet Eng Biotechnol
. 2023 Dec;
21(1):171.
PMID: 38112983
We isolated two novel bacterial strains, active against the environmental pollutant acetaminophen/Paracetamol®. Streptomyces chrestomyceticus (symbol RS2) and Flavofuscus (symbol M33) collected from El-Natrun Valley, Egypt-water, sediment, and sand samples, taxonomically...
6.
Kotb R, Afifi A, El-Houseini M, Ezz-Elarab M, Basalious E, Omran M, et al.
Discov Oncol
. 2023 Sep;
14(1):169.
PMID: 37704828
Background: This is a phase II clinical trial to investigate the immunotherapeutic effect of Curcumin, Piperine, and Taurine (CPT) combination in hepatocellular carcinoma (HCC). Methods: Twenty-six HCC patients aged (50-80...
7.
Farag M, El-Sebaie W, Basalious E, El-Gazayerly O
AAPS PharmSciTech
. 2023 May;
24(5):120.
PMID: 37173539
The current study is regarding the development and characterization of Darifenacin-loaded self-assembled liquid crystal cubic nanoparticles (LCCN). An anhydrous approach was used for the preparation of these cubic nanoparticles using...
8.
ElShagea H, Makar R, Salama A, Elkasabgy N, Basalious E
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839855
Rasagiline mesylate (RSM) is a hydrophilic drug with poor oral bioavailability (36%) because of hepatic first-pass metabolism. The present study focuses on delivering RSM directly to the brain through its...
9.
Bhattacharya K, Shamkh I, Khan M, Lotfy M, Nzeyimana J, Abutayeh R, et al.
Vaccines (Basel)
. 2022 Dec;
10(12).
PMID: 36560421
(1) Background: The monkeypox virus is a zoonotic orthopox DNA virus that is closely linked to the virus. In light of the growing concern about this virus, the current research...
10.
Hamdy N, Eskander G, Basalious E
Int J Nanomedicine
. 2022 Dec;
17:6131-6155.
PMID: 36514378
Anti-cancer conventional chemotherapeutic drugs novel formula progress, nowadays, uses nano technology for targeted drug delivery, specifically tailored to overcome therapeutic agents' delivery challenges. Polymer drug delivery systems (DDS) play a...